Clinical Trials Browser

Phase 2 × Breast Neoplasm Female × penpulimab × Clear all

NCT05244993 2022-07-12

AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer

Phase 2 Unknown

Breast Neoplasm Female